Navigation Links
CryoCath Introduces Arctic Front in Australia
Date:3/26/2008

Toronto Stock Exchange Symbol: CYT

http://www.cryocath.com

MONTREAL, March 26 /PRNewswire-FirstCall/ - CryoCath(R) Technologies Inc., the global leader in cryotherapy products to treat cardiac arrhythmias, today announced the introduction of Arctic Front(R) in Australia. Arctic Front, the company's lead product for the treatment of paroxysmal atrial fibrillation (PAF), is a unique cryoablation balloon catheter that allows physicians to safely and effectively isolate all four pulmonary veins to stop PAF.

On March 13 and 14, a group of nine Australian electrophysiologists attended the training program for the Arctic Front system in Melbourne, Australia. Leadership of this program was in the hands of Dr. Jeff Alison, Head of Electrophysiology and Pacing of the Monash Medical Centre in Melbourne, Australia, and Dr. Yves Van Belle of the Thorax Centrum at the Erasmus University in Rotterdam, The Netherlands. Dr. Van Belle is one of the most experienced users of the Arctic Front system and the author of the first publication on this groundbreaking device in a peer reviewed journal. Dr. Alison has received training on the system both in Germany as well as in Montreal. He has also performed the first Arctic Front procedure in Australia in late 2007.

"Arctic Front holds the promise of a breakthrough therapy in the treatment of paroxysmal atrial fibrillation. The data out of Europe strongly supports this belief and we're excited to be able to offer a potentially safer and effective treatment to our patients," said Dr. Alison. "Thousands of Australians suffer from the symptoms of PAF, and a safe and effective therapy can bring a substantial benefit to these patients."

Solid professional education is the foundation of a successful introduction of a new technology. In the first Arctic Front Masters Program (AFMP) held in Australia, nine physicians from two centers were trained on the new technology. As part of the curriculum, they observed two successful procedures performed by Dr. Alison. Through the efforts of Life Systems Medical Inc., CryoCath's exclusive distributor in Australia, an extensive follow-up training program was completed. As a result of this successful program, several first Arctic Front procedures were performed in two further hospitals across Australia over the past few days.

"We're happy to see the rapid growth in the use of Arctic Front now expanding beyond Europe. The rapidly increasing body of positive clinical evidence for the Arctic Front system gives us great confidence that we can continue to show a fast expansion of our user base," said Jan Keltjens, President and CEO of CryoCath. "I am impressed with the efforts of Life Systems Medical and the support from thought leaders in Australia. Well over 2,000 patients across 34 centres in Europe have been treated to date with Arctic Front. The introduction in Australia will further accelerate this momentum and bring the benefits of this breakthrough therapy to large groups of patients."

About CryoCath

CryoCath - http://www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, see CryoCath's annual report available at http://www.sedar.com under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.


'/>"/>
SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Appoints New Chief Financial Officer
2. CryoCath Technologies notice of annual meeting
3. CryoCath Announces Fiscal 2008 First Quarter Results
4. CryoCath Provides Update on Patent Infringement Lawsuit
5. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
6. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
7. CryoCath announces 2007 fourth quarter and fiscal year end financial results
8. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
9. CryoCath to present at CIBC Healthcare Conference
10. CryoCath files patent infringement lawsuit
11. SOYJOY(R) Introduces Two New Ways to Enjoy Soy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Spectrum Aquatics has launched a brand ... been designed and built with the user in mind. , “Over the last two ... us that an ADA 400 lbs lift is a necessary requirement for certain facilities ...
(Date:5/31/2016)... Dallas, TX (PRWEB) , ... May 31, 2016 , ... ... Center – Vidalia, GA; Houston Methodist – Houston, TX and Shore Medical Center – ... 1,000 and use three different, leading EHR solutions, demonstrating the breadth of Phynd’s solution ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 Inc. , Each ... series of research reports evaluating these innovative vendors and their products and services. ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/30/2016)... ... 30, 2016 , ... As the CDC relaxes its stance on traditional No-Nit ... keep their households lice free. , According to a May 26 article from ... kids in the classroom despite the fact that they may be harboring an infestation. ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... 2016 194 Mitgliedsstaaten ... Eliminierung von viraler Hepatitis    Am ... eingegangen, virale Hepatitis bis 2030 zu eliminieren. ... Assembly haben sich die Staaten einstimmig dafür entschieden, ... Viral Hepatitis Strategy) zu verabschieden, was das bisher ...
(Date:5/30/2016)... , May 30, 2016 ... "Healthcare Analytical Testing Services Market by Type (Stability, ... Services), by End User (Pharmaceutical Companies, Medical Device ... MarketsandMarkets, The market witnessed healthy growth during the ... a CAGR of 11.3% between 2016 and 2021 ...
(Date:5/30/2016)... , May 30, 2016 ... 2016" market research report with comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
Breaking Medicine Technology: